1-5 of 5
Herlander Marques
Close
Sort by
Journal Articles

The International Multiple Myeloma Research (IMMEnSE) Consortium: Genetics of Multiple Myeloma Risk and Prognosis

Federico Canzian, PhD, Katia Beider, PhD, Gabriele Buda, MD, Felipe de Arriba de la Fuente, Marek Dudzinski, MD PhD, Charles Dumontet, MD PhD, Ramon Garcia-Sanz, Hiroshi Handa, MD PhD, Krzysztof Jamroziak, MD PhD, Manuel Jurado, MD, Artur J. Jurczyszyn, MD PhD, Stefano Landi, MD PhD, Fabienne Lesueur, PhD, Herlander Marques, Joaquín Martínez-López, MD PhD, Victor Moreno, Hirokazu Murakami, MD PhD, Arnon Nagler, MD, Mario Petrini, MD PhD, Rui Manuel Reis, MD PhD, Rafael Rios, Juan Sainz, Zofia Szemraj-Rogucka, MD PhD, Annette Juul Vangsted, MD, Judit Varkonyi, Ulla Vogel, MD PhD, Marzena Watek, MD, Daniele Campa, PhD
Journal: Blood
Blood (2014) 124 (21): 3421.
https://doi.org/10.1182/blood.V124.21.3421.3421
Published: 2014
Journal Articles

Type 2 Diabetes-Related Variants Influence on the Risk of Developing Multiple Myeloma: Results from the Immense Consortium

Juan Sainz, PhD, Carmen Belén Lupiañez, Daniele Campa, PhD, Gabriele Buda, MD, Hernan Jose Moreno, MD, Marek Dudziński, PhD, Charles Dumontet, MD PhD, Ramón García-Sanz, MD PhD, Krzysztof Jamroziak, MD PhD, Artur J. Jurczyszyn, MD PhD, Stefano Landi, MD PhD, Fabienne Lesueur, PhD, Herlander Marques, MD PhD, Joaquín Martínez-López, MD PhD, Victor Moreno, MD PhD, Mario Petrini, MD PhD, Rui Manuel Reis, MD PhD, Zofia Szemraj-Rogucka, MD PhD, Annette Juul Vangsted, MD PhD, Judit Varkonyi, MD PhD, Ulla Vogel, MD PhD, Marzena Wątek, MD PhD, Federico Canzian, PhD, Rafael Rios, MD
Journal: Blood
Blood (2014) 124 (21): 2044.
https://doi.org/10.1182/blood.V124.21.2044.2044
Published: 2014
Journal Articles

Polymorphisms in Regulators of Xenobiotic Transport and Metabolism Genes NR1I2 and NR1I3 and Multiple Myeloma Risk: A Case-Control Study in the Context of IMMEnSE Consortium

Gabriele Buda, M.D., PhD, Alessandro Martino, PhD, Daniele Campa, Juan Sainz, Rui Manuel Vieira Reis, Ramón García-Sanz, Krzysztof Jamroziak, Rafael Rios, Manuel Jurado, Zofia Szemraj-Rogucka, Herlander Marques, Victor Moreno, Fabienne Lesueur, Charles Dumontet, M. D., Ph. D., Federica Gemignani, Stefano Landi, Enrico Orciuolo, Anna Maria Rossi, Mario Petrini, MD, Federico Canzian
Journal: Blood
Blood (2011) 118 (21): 5014.
https://doi.org/10.1182/blood.V118.21.5014.5014
Published: 2011
Journal Articles

Health Outcomes and Costs of Rituximab in Combination with Cyclophosphamide, Vincristine and Prednisolone in the Treatment of Patients with Advanced Follicular Lymphoma in Portugal.

Paula Braga, Susana Carvalho, Marília Gomes, Lurdes Guerra, Paulo Lúcio, Herlander Marques, Filipa Negreiro, Statistician, Catarina Pereira, Catarina Silva, Senior, Statistician, Adriana Teixeira
Journal: Blood
Blood (2009) 114 (22): 2481.
https://doi.org/10.1182/blood.V114.22.2481.2481
Published: 2009
Journal Articles

Predictive Factors of Relative Dose Intensity Reduction in Clinical Practice for First Line Treatment in Patients with Non-Hodgkin and Hodgkin Lymphoma

Ana Marques Pereira, MD, Maria do Céu Trindade, MD, Jorge Espírito Santo, MD, Ricardo Costa, Adriana Teixeira, Emília Magalhães, MD, Rute Vieira, Herlander Marques, MD
Journal: Blood
Blood (2008) 112 (11): 5006.
https://doi.org/10.1182/blood.V112.11.5006.5006
Published: 2008